IN8BIO, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
In8 Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • In8 Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$8.63M, a 11.8% decline year-over-year.
  • In8 Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$32M, a 5% decline year-over-year.
  • In8 Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30M, a 5.21% decline from 2022.
  • In8 Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$28.5M, a 94.6% decline from 2021.
  • In8 Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.7M, a 71.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$32M -$8.63M -$914K -11.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$31M -$8.56M -$1.04M -13.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 -$30M -$7.6M +$200K +2.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$30.2M -$7.17M +$230K +3.11% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$30.4M -$7.72M -$536K -7.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$29.9M -$7.53M -$1.38M -22.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$28.5M -$7.8M -$1.95M -33.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$26.6M -$7.4M -$4.01M -118% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$22.6M -$7.18M -$4.13M -135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$18.4M -$6.15M -$3.78M -160% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$14.7M -$5.85M -$3.54M -153% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$11.1M -$3.39M -$1.71M -102% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$9.41M -$3.05M -$176K -6.12% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$9.23M -$2.36M -$672K -39.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$8.56M -$2.31M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$1.68M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$2.87M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$1.69M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.